Bioxytran (BIXT) Stock Chart & Stock Price History → Trump’s arrest is phase one (From Porter & Company) (Ad) Free BIXT Stock Alerts $0.12 -0.01 (-7.87%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Bioxytran Stock Price Performance5 Day Performance-11.90%1 Month Performance+11.96%3 Month Performance+1.74%6 Month Performance+0.43%Year-To-Date Performance-22.00%1 Year Performance-66.57% Receive BIXT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bioxytran and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. BIXT Stock Chart for Saturday, June, 1, 2024 BIXT Chart by TradingView Bioxytran Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$0.12$0.12+0.08%$0.12$0.1275,219 shs$21.91 million05/30/2024$0.13$0.12-3.78%$0.13$0.1257,963 shs$21.89 million05/29/2024$0.12$0.13+8.44%$0.13$0.1218,868 shs$22.75 million05/28/2024$0.13$0.12-9.94%$0.13$0.1253,500 shs$20.98 million05/27/2024$0.13$0.13+0.04%$0.14$0.1342,300 shs$23.29 million05/24/2024$0.13$0.13-0.15%$0.14$0.1342,319 shs$23.29 million Get the Latest News and Ratings for BIXT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bioxytran and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$0.14$0.13-5.00%$0.13$0.1356,200 shs$23.33 million05/22/2024$0.14$0.14+3.32%$0.14$0.1313,300 shs$24.56 million05/21/2024$0.15$0.14-7.19%$0.15$0.1370,321 shs$23.77 million05/20/2024$0.13$0.15+16.52%$0.15$0.13125,155 shs$25.61 million05/17/2024$0.12$0.13+1.05%$0.13$0.128,454 shs$21.92 million05/16/2024$0.13$0.12-3.88%$0.13$0.1210,734 shs$21.70 million05/15/2024$0.13$0.13+2.58%$0.14$0.13178,681 shs$22.57 million05/14/2024$0.12$0.13+9.35%$0.13$0.12152,000 shs$22.00 million05/13/2024$0.11$0.12+3.98%$0.12$0.11174,409 shs$20.12 million05/10/2024$0.11$0.11+0.55%$0.11$0.11108,330 shs$19.35 million05/09/2024$0.11$0.11+4.76%$0.11$0.11263,114 shs$19.25 million05/08/2024$0.11$0.11-2.33%$0.11$0.10134,267 shs$18.37 million05/07/2024$0.10$0.11+5.39%$0.11$0.1044,782 shs$18.81 million05/06/2024$0.10$0.10+0.94%$0.11$0.1073,954 shs$17.85 million05/03/2024$0.10$0.10+1.00%$0.10$0.1095,506 shs$17.69 million05/02/2024$0.10$0.10-4.21%$0.10$0.1080,911 shs$17.51 million05/01/2024$0.11$0.10-5.94%$0.11$0.10104,504 shs$18.28 million04/30/2024$0.11$0.11+1.37%$0.11$0.1142,858 shs$19.44 million04/29/2024$0.12$0.11-8.67%$0.12$0.1191,490 shs$19.18 million04/26/2024$0.14$0.12-11.11%$0.14$0.1168,741 shs$20.88 million04/25/2024$0.13$0.14+8.00%$0.14$0.1314,800 shs$23.49 million04/24/2024$0.15$0.13-14.38%$0.15$0.12212,949 shs$21.75 million04/23/2024$0.14$0.15+3.55%$0.15$0.15116,400 shs$25.40 million04/22/2024$0.13$0.14+6.42%$0.14$0.1355,445 shs$24.53 million04/19/2024$0.13$0.13+3.11%$0.15$0.12288,748 shs$23.05 million04/18/2024$0.12$0.13+4.47%$0.13$0.1231,600 shs$21.39 million04/17/2024$0.12$0.12+5.13%$0.13$0.1233,500 shs$20.48 million04/16/2024$0.15$0.12-19.76%$0.15$0.12134,011 shs$19.48 million04/15/2024$0.15$0.15-2.79%$0.15$0.1431,600 shs$24.28 million04/12/2024$0.14$0.15+4.68%$0.15$0.14296,658 shs$24.97 million04/11/2024$0.13$0.14+10.23%$0.14$0.14301,619 shs$23.86 million04/10/2024$0.13$0.13$0.14$0.12164,500 shs$21.64 million04/09/2024$0.14$0.13-6.12%$0.14$0.11164,500 shs$21.64 million04/08/2024$0.12$0.14+13.04%$0.14$0.14359,499 shs$23.05 millionTrump conviction scandal exposed (Ad)In this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now.04/05/2024$0.12$0.14+13.06%$0.14$0.10359,499 shs$23.06 million04/04/2024$0.11$0.12+9.47%$0.12$0.12288,091 shs$20.40 million04/03/2024$0.11$0.11$0.12$0.11248,375 shs$18.63 million04/02/2024$0.11$0.11+1.73%$0.12$0.10243,375 shs$18.53 million04/01/2024$0.11$0.11+3.97%$0.11$0.1097,187 shs$18.22 million03/29/2024$0.11$0.11$0.11$0.1048,608 shs$17.52 million03/28/2024$0.10$0.11+4.75%$0.11$0.1048,608 shs$17.52 million03/27/2024$0.10$0.10-2.98%$0.10$0.1040,400 shs$16.73 million03/26/2024$0.11$0.10-5.45%$0.11$0.1089,807 shs$17.24 million03/25/2024$0.12$0.11-4.26%$0.12$0.1179,699 shs$18.23 million03/22/2024$0.11$0.12+3.14%$0.12$0.1137,490 shs$19.04 million03/21/2024$0.12$0.11-5.11%$0.11$0.1110,200 shs$18.46 million03/20/2024$0.11$0.12+5.10%$0.12$0.11100,197 shs$19.46 million03/19/2024$0.12$0.11-5.33%$0.13$0.1140,766 shs$18.51 million03/18/2024$0.11$0.12+6.21%$0.12$0.1230,664 shs$19.56 million03/15/2024$0.12$0.11-10.68%$0.12$0.1161,515 shs$18.41 million03/14/2024$0.12$0.12+5.51%$0.13$0.1247,266 shs$20.62 million03/13/2024$0.13$0.12-5.60%$0.13$0.1239,806 shs$19.54 million03/12/2024$0.12$0.13+8.70%$0.13$0.1228,769 shs$20.70 million03/11/2024$0.11$0.12+1.19%$0.13$0.11114,066 shs$19.04 million03/08/2024$0.12$0.11-5.25%$0.12$0.113,166 shs$18.83 million03/07/2024$0.12$0.12$0.13$0.1232,123 shs$19.87 million03/06/2024$0.11$0.12+14.29%$0.15$0.11360,250 shs$19.87 million03/05/2024$0.11$0.11-5.66%$0.11$0.11114,618 shs$17.39 million03/04/2024$0.12$0.11-3.22%$0.12$0.1141,045 shs$18.43 million03/01/2024$0.11$0.12+4.55%$0.12$0.11119,852 shs$19.04 million02/29/2024$0.12$0.11-6.38%$0.12$0.1122,180 shs$18.22 million Related Companies: Unity Biotechnology Stock Chart Iterum Therapeutics Stock Chart Lisata Therapeutics Stock Chart Bullfrog AI Stock Chart Cumberland Pharmaceuticals Stock Chart BriaCell Therapeutics Stock Chart TherapeuticsMD Stock Chart NeuroBo Pharmaceuticals Stock Chart NanoViricides Stock Chart Rezolute Stock Chart Receive BIXT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bioxytran and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:BIXT) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioxytran, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.